Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. BEFORE Study
Latest Information Update: 29 Jun 2023
At a glance
- Drugs Bezlotoxumab (Primary)
- Indications Clostridium difficile infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms BEFORE
Most Recent Events
- 23 Jun 2023 Status changed from recruiting to completed.
- 03 Feb 2020 Status changed from not yet recruiting to recruiting.
- 05 Sep 2019 New trial record